SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001078782-17-000912
Filing Date
2017-06-23
Accepted
2017-06-23 18:06:45
Documents
1
Period of Report
2017-05-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2621
  Complete submission text file 0001078782-17-000912.txt   4121
Mailing Address 5 ROCKEFELLER PLAZA 20TH FLOOR NEW YORK NY 10022
Business Address 5 ROCKEFELLER PLAZA 20TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Issuer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 ROCKERFELLER PLACE, 20TH FLOOR SUITE 83 NEW YORK NY 10111
Business Address
Scott Timothy Richard (Reporting) CIK: 0001709014 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54296 | Film No.: 17928587